These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1136 related articles for article (PubMed ID: 32036033)
1. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease. Butterfield DA; Mattson MP Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033 [TBL] [Abstract][Full Text] [Related]
2. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice. Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773 [TBL] [Abstract][Full Text] [Related]
3. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Butterfield DA; Castegna A; Lauderback CM; Drake J Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766 [TBL] [Abstract][Full Text] [Related]
4. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Butterfield DA Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822 [TBL] [Abstract][Full Text] [Related]
5. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease. Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632 [TBL] [Abstract][Full Text] [Related]
7. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. Aleshkov S; Abraham CR; Zannis VI Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639 [TBL] [Abstract][Full Text] [Related]
8. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk. Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998 [TBL] [Abstract][Full Text] [Related]
9. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention. Keeney JT; Ibrahimi S; Zhao L J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005 [TBL] [Abstract][Full Text] [Related]
10. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging. Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682 [TBL] [Abstract][Full Text] [Related]
11. A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. Pedersen WA; Chan SL; Mattson MP J Neurochem; 2000 Apr; 74(4):1426-33. PubMed ID: 10737598 [TBL] [Abstract][Full Text] [Related]
12. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669 [TBL] [Abstract][Full Text] [Related]
13. Isoform-specific modification of apolipoprotein E by 4-hydroxynonenal: protective role of apolipoprotein E3 against oxidative species. Abeer MI; Abdulhasan A; Haguar Z; Narayanaswami V FEBS J; 2023 Jun; 290(11):3006-3025. PubMed ID: 36661393 [TBL] [Abstract][Full Text] [Related]
14. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy. Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide. Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062 [TBL] [Abstract][Full Text] [Related]
17. The interaction of amyloid-beta with ApoE. Carter DB Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483 [TBL] [Abstract][Full Text] [Related]
18. Effect of apoE genotype and vitamin E on biomarkers of oxidative stress in cultured neuronal cells and the brain of targeted replacement mice. Huebbe P; Jofre-Monseny L; Boesch-Saadatmandi Ch; Minihane AM; Rimbach G J Physiol Pharmacol; 2007 Dec; 58(4):683-98. PubMed ID: 18195481 [TBL] [Abstract][Full Text] [Related]
19. Isoform-specific effects of apoE on neurite outgrowth in olfactory epithelium culture. Hussain A; Luong M; Pooley A; Nathan BP J Biomed Sci; 2013 Jul; 20(1):49. PubMed ID: 23845000 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology. Baum L; Chen L; Ng HK; Pang CP Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]